Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.

Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine... A prospective randomized clinical study was conducted. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Spine Pubmed

Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.

Boden, Scott D; Kang, James; Sandhu, Harvinder; Heller, John G
Spine , Volume 27 (23): -2588 – Jan 15, 2003
Download PDF

Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.


Abstract

A prospective randomized clinical study was conducted.

Loading next page...
 
/lp/pubmed/use-of-recombinant-human-bone-morphogenetic-protein-2-to-achieve-1Z3w301in1

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0362-2436
DOI
10.1097/00007632-200212010-00005
pmid
12461392

Abstract

A prospective randomized clinical study was conducted.

Journal

Spine – Pubmed

Published: Jan 15, 2003

There are no references for this article.